EMA has engaged a specialised third-party service provider to support the full investigation that is currently being carried out in close cooperation with law enforcement and other relevant entities. This company will contribute to the additional security measures that are being put in place in response to the data breach.

So far, the investigation has revealed that a limited number of documents belonging to third parties were unlawfully accessed. The concerned third parties identified at this stage have been contacted and duly informed.

The Agency remains fully functional and its timelines related to the evaluation and approval of COVID-19 vaccines and treatments are not affected.

EMA will continue to provide information in due course, to the extent possible, given its duty towards the ongoing investigations.

Share this page